Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes

Journal of Laboratory and Clinical Medicine

Volumn 136, Issue 3, 2000, Pages 194-200

  Berger, Mario ^a   Schröder, Babette ^a   Daeschlein, Georg ^a   Schneider, Wolfgang ^a   Busjahn, Andreas ^a   Buchwalow, Igor ^a   Luft, Friedrich C ^a   Haller, Hermann ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BACTERIAL DNA; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; POLYMERASE CHAIN REACTION; RIBOSOMAL RNA; SERODIAGNOSIS;

CHLAMYDIA PNEUMONIAE;

EID: 0033806948     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.108941     Document Type: Article

References (35)

1. Infection and atherosclerosis: Emerging mechanistic paradigms
2. Infection and inflammation as risk factors for myocardial infarction
3. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
4. Chlamydia pneumoniae infection in human monocytes
5. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes
6. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-age blood donors
7. Current knowledge of Chlamydia pneumoniae and atherosclerosis
8. Evaluation of Chlamydia immunoglobulin M (IgM), IgG, and IgA rELISAs Medac for diagnosis of Chlamydia pneumoniae infection
9. Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients
10. Comparison of two serological methods and a polymerase chain reaction-enzyme immunoassay for the diagnosis of acute respiratory infections with Chlamydia pneumoniae in adults
11. The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae
12. Detection of Chlamydia pneumoniae by polymerase chain reaction
13. Gene typing of Chlamydia trachomatis by polymerase chain reaction and restriction endonuclease digestion
14. Comparison of Chlamydia pneumoniae isolates by Western blot (immunoblot) analysis and DNA sequencing of hte OMP 2 gene
15. Susceptibility of Chlamydia pneumoniae to azithromycin and doxycycline: Methological aspects on the determinations of minimal inhibitory and minimal bactericidal concentrations
16. Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers
17. High incidence of Chlamydia pneumoniae in sclerotic heart valves of patients undergoing aortic valve replacement
18. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque
19. Comparative genomes of Chlamydia pneumoniae and C. trachomatis
20. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease
21. Importance of smoking for Chlamydia pneumoniae seropositivity
22. Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD
23. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery
24. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications
25. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen
26. Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction
27. Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery
28. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms
29. Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneursyms by a nested polymerase chain reaction (PCR)
30. Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease
31. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
32. In vitro susceptibility of human vascualr wall cells to infection with Chlamydia pneumoniae
33. Chlamydia pneumoniae infection in human monocytes
34. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae